This report is designed for companies and decision-makers seeking actionable insights on market size, growth, trends, and competitive strategies to drive expansion and success in the Oral Thin Films industry.
What is the projected value of the oral thin films market by 2029?
The oral thin films market size has grown rapidly in recent years. It will grow from $4.48 billion in 2024 to $5.03 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to patient compliance, pediatric and geriatric patients, rapid drug delivery, chronic diseases, over-the-counter (otc) medications.
The oral thin films market size is expected to see rapid growth in the next few years. It will grow to $8.72 billion in 2029 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to specialty pharmaceuticals, precision medicine, mental health medications, oral vaccines, telemedicine services. Major trends in the forecast period include drug delivery technologies, remote care, bioavailability enhancement, travel and on-the-go usage, allergen-free formulations.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6067&type=smp
How are technological advancements fueling growth in the oral thin films market?
Rising demand for thin film drug delivery systems is propelling the growth of the oral thin film market. Thin films have been identified as a potential alternative to standard dosage forms. It is a convenient, self-administrable, and fast-dissolving dosage form for the delivery of medications, which makes it a versatile drug delivery platform. Thin films are taken orally and do not require water to be swallowed to absorb a drug. OTF is more patient-friendly due to its rapid dissolution rate. Due to these reasons, the demand for thin-film drug delivery systems is increasing, which is bringing more demand for oral thin films as well. In the United States, cardiovascular disease affects over half of all individuals. For instance, In January 2023, a report from The American Cancer Society, a US-based non-profit organization, At least 42% of newly diagnosed cancers in the US, excluding non-melanoma skin cancer, account for approximately 820,000 cases in 2023 and 840,000 cases in 2024, highlighting the growing need for advanced drug delivery methods to ensure effective treatment. Thus, increasing demand for thin film drug delivery systems is driving the growth of the oral thin film market.
Which segment currently leads the oral thin films market in terms of revenue share?
The oral thin films market covered in this report is segmented –
1) By Type: Sublingual Film, Fast Dissolving Dental/Buccal Film
2) By Disease Indication: Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting, Other Disease Indication
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
Subsegments:
1) By Sublingual Film: Drug Delivery Films, Nutritional Supplement Films
2) By Fast Dissolving Dental Or Buccal Film: Over-the-Counter (OTC) Products, Prescription Products
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/oral-thin-films-global-market-report
What are the top market trends driving innovation in the oral thin films industry?
Major companies operating in the oral thin films market are focusing on innovative products such as Rizaport to drive revenues in their market. Rizaport is a brand-name oral thin-film formulation that contains rizatriptan benzoate, an agonist of the 5-HT1 receptor and the active ingredient of Merck & Co.’s Maxalt. For instance, in February 2024, CD Formulation, a US-based drug formulation company, launched the oral thin film technology. This offers user-friendly administration, particularly for patients with swallowing difficulties, and ensures rapid absorption by dissolving in the oral cavity, bypassing the digestive system for faster onset of action. This novel drug delivery system enhances bioavailability, allows precise dosing for individualized treatment, and improves convenience and medication adherence, especially in emergency situations.
Who are the top competitors in the global oral thin films market?
Major companies operating in the oral thin films market include ZIM Laboratories Limited, NAL Pharma, Cure Pharmaceutical Holding Corp., IntelGenx Corp., Kyu Kyu Pharmaceutical Co. Ltd., Sunovion Pharmaceuticals Inc., Seoul Pharma Co. Ltd., Aquestive Therapeutics Inc., Shilpa Therapeutics Pvt. Ltd., Mylan Inc., LIVKON Pharmaceuticals Pvt. Ltd., Panacea Biotec Ltd., Adare Pharmaceuticals Inc., APR Applied Pharma Research SA, BioDelivery Sciences International Inc., Sumitomo Dainippon Pharma Co. Ltd., Indivior PLC, LTS Lohmann Therapie-Systeme AG, Tesa Labtec GmbH, Pfizer Inc., Sanofi S.A., Merck & Co. Inc., Novartis International AG, Roche Holding AG, Johnson & Johnson, GlaxoSmithKline plc, Bayer AG, Eli Lilly and Company, AbbVie Inc., Bristol-Myers Squibb Company, Novo Nordisk A/S, AstraZeneca plc
What regional dynamics are shaping the future of the global oral thin films market?
North America was the largest region in the oral thin film market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral thin films market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
How Can Companies Use The Oral Thin Films Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6067
Need Customized Data On Oral Thin Films Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/customise?id=6067&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
